Invention Application
- Patent Title: METHODS FOR TREATING MEIBOMIAN GLAND DYSFUNCTION WITH LIVER X RECEPTOR AGONISTS
-
Application No.: US17625201Application Date: 2020-07-13
-
Publication No.: US20220257596A1Publication Date: 2022-08-18
- Inventor: Christopher M. ADAMS , Qian HUANG , Sandra TEIXEIRA , Brett THIBODEAUX
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- International Application: PCT/IB2020/056584 WO 20200713
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61K31/405 ; A61K31/454 ; A61K31/195 ; A61K31/497 ; A61K31/18 ; A61K31/415 ; A61K31/4174 ; A61K31/137 ; A61K31/496 ; A61K31/416 ; A61K31/4545 ; A61K9/00 ; A61P27/14
Abstract:
The present invention provides methods for treating meibomian gland dysfunction using liver X receptor (LXR) agonists.
Information query
IPC分类:
